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Abstract 
Adenosquamous carcinoma (ASC) and pure squamous cell carcinoma (SCC) of the 
pancreas are very rare diseases. The author herein reports two cases of ASC and SCC of 
the pancreas. The first case is ASC. An 80-year-old woman was admitted to our hospital 
because of abdominal pain and weakness. Imaging modalities including CT, MRI and 
ERCP revealed a pancreatic body tumor. Distal partial resection of the pancreas and 
splenectomy were performed. Grossly, an infiltrative solid tumor measuring 3 × 4 × 4 cm 
was present in the pancreatic body. Histologically, it was an ASC consisting of poorly 
differentiated adenocarcinoma element (20% in area) and SCC element (80%). There was 
a gradual transition between the two. Many perineural invasions and lymphovascular 
permeations were recognized. The patient died of systemic metastasis five months after 
operation. The second case is an SCC. A 69-year-old woman presented with abdominal 
pain and jaundice. Imaging modalities including CT, MRI and ERCP revealed a tumor in 
the head of the pancreas. Pancreaticoduodenectomy was performed. Grossly, an 
infiltrative solid tumor measuring 5 × 5 × 6 cm was present. Histologically, the tumor was 
pure SCC. The SCC was moderately differentiated SCC. A large number of perineural 
invasions and lymphovascular permeations were present. The patient died of systemic 
metastasis three months after operation. The author speculates that ASC of the pancreas 
may be derived from squamous tansdifferentiation of adenocarcinoma element or from 
pluripotent stem cells, and that SCC of the pancreas may arise from malignant 
transformation of squamous metaplasia of pancreatic ducts or from pluripotent stem 
cells.  
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Introduction 
Adenosquamous carcinoma (ASC) of the pancreas is very rare, its incidence being  
3–4% of all pancreatic malignancies [1]. ASC of the pancreas has been sporadically 
reported as case reports, and there are several comprehensive reports of a relatively large 
series [2–5]. Squamous cell carcinoma (SCC) of the pancreas is a much rarer disease. A 
few case reports have been published [6–9], but there are no comprehensive studies of 
large series. The author reports herein one case of ASC and one case of pure SCC of the 
pancreas. 
Case 1 
An 80-year-old woman was admitted to our hospital because of abdominal pain and weakness. 
Imaging modalities including CT, MRI and ERCP revealed a pancreatic body tumor. Distal partial 
resection of the pancreas and splenectomy were performed. Grossly, an infiltrative solid tumor 
measuring 3 × 4 × 4 cm was recognized. Histologically, it was an ASC consisting of moderately to poorly 
differentiated adenocarcinoma element (20% in area) (fig. 1a) and SCC element (80%) (fig. 1b). There 
was a gradual transition between the two. There were also equivocal malignant cells as to SCC and 
adenocarcinoma. Areas of pleomorphism and tumor giant cells were present. The adenocarcinoma cells 
were positive with PAS and alcian blue staining, indicating positive mucins. Numerous perineural 
invasions and lymphovascular permeations were recognized. The tumor cells invaded the peripancreatic 
fat tissue. The patient died of systemic metastasis five months after operation.  
Case 2 
A 69-year-old woman was admitted to our hospital with abdominal pain and jaundice. 
Imaging modalities including CT, MRI and ERCP revealed a tumor in the head of the pancreas. 
Pancreaticoduodenal resection and cholecystectomy were performed. Grossly, an infiltrative solid 
tumor measuring 5 × 5 × 6 cm was recognized. Histologically, the tumor is pure SCC (fig. 2a). The SCC 
was moderately differentiated SCC with keratinization (fig. 2b) and intercellular bridges (fig. 2c). Many 
perineural invasions and lymphovascular permeations were present. The tumor cells invaded the 
extrahepatic bile duct, duodenum and peripancreatic fat tissue and involved peripancreatic lymph 
nodes. The patient died of systemic metastasis three months after operation.  
Discussion 
According to the WHO classification [10], ASC is defined as a rare pancreatic 
neoplasm characterized by the presence of a variable proportion of mucin-producing 
glandular elements and squamous components. The squamous component should 
account for at least 30% of the tumor tissue. Our case 1 fulfills these criteria.  
ASC of the pancreas is a rare tumor with an incidence of 3–4% of all pancreatic 
malignancies [1, 10]. This neoplasm is an aggressive tumor with a poor prognosis. The 
mean prognosis period is about six months [1, 2, 4]; it is shorter than for ordinary ductal 
adenocarcinoma of the pancreas [10]. The most involved site is the pancreatic head, 
followed by the body and tail [4]. In the present case of ASC, the prognosis was five 
months, and the ASC was present in the body of the pancreas. 
The pathogenesis of ASC is unclear. Two theories exist: (1) the squamous element is 
derived from squamous transdifferentiation of adenocarcinoma element; (2) the ASC of  
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the pancreas arises from pluripotent stem cells. In our case, the adenocarcinoma and 
squamous elements were mixed up, and a gradual transition was recognized between the 
two. 
SSC of the pancreas is much rarer than ASC. The exact incidence is unknown. There 
are a few case reports of SCC of the pancreas [6–9], but no comprehensive reports of large 
series. This entity is not listed in the WHO book [10].  
An analysis of the four cases reported previously [6–9] shows that SCC is an 
aggressive tumor with a poor prognosis, like ASC of the pancreas. In the present SCC 
of the pancreas, the prognosis was only three months. The pathogenesis of SCC of the 
pancreas is unknown. The author speculates that SCC of the pancreas may be derived 
from malignant transformation of squamous metaplasia of pancreatic ducts, or may arise 
from pluripotent stem cells in the pancreas. 
 
 
 
 
 
 
Fig. 1. Histology of case 1 (ASC). Tumor cells are composed of adenocarcinoma (moderately to poorly 
differentiated adenocarcinoma) element (a) and SCC element (b). a HE, ×200. b HE, ×150. 
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Fig. 2. Histology of case 2 (pure SCC). Tumor cells are composed of monotonous proliferation of SCC 
(a). The carcinoma cells show keratinization (b) and intercellular bridges (c). a HE, ×40. b HE; ×150. 
c HE, ×200. 
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